Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

Similar documents
NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

BLS International Services

Healty cigarette-driven growth

Crompton Greaves Consumer Electricals

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Crompton Greaves Consumer Electricals

Growth + cash flows = BUY

Multi Commodity Exchange

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Intellect Design Arena

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Near-term pressure, but long-term outlook positive

Navin Fluorine International

Discounting $45/bbl of realisation

J. Kumar Infraprojects

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

Central Depository Services

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Central Depository Services

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Central Depository Services

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Carborundum Universal

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Kalpataru Power Transmission

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Strong volumes, offset by costs

Jubilant Life Sciences

Hindustan Petroleum Corporation

Hindustan Petroleum Corporation

Dishman Carbogen Amcis

Geared for version 3.0

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

ICICI Prudential Life

Bharat Forge. Cyclical headwinds persist but structural story intact BUY COMPANY UPDATE 9 DEC Key takeaways

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Crompton Greaves Consumer Electricals

J. Kumar Infraprojects

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

Weak numbers in peak quarter

Navin Fluorine International

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Bharat Petroleum Corporation

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Coromandel International

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

Pre-sales pickup key trigger

Multi Commodity Exchange

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

Hexaware Technologies

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

Margin boost through non-core book

Lupin BUY COMPANY UPDATE 12 SEP 2013

Coal India. Tough times BUY COMPANY UPDATE 22 AUG CMP (as on 21 Aug 17) Rs 238 Target Price Rs 300

Weak quarter but well placed

Autos. 4QFY18E Results Preview. 12 Apr Abhishek Jain

Mindtree. Steady quarter, Upside capped NEUTRAL RESULTS REVIEW 4QFY19 18 APR INDUSTRY CMP (as on 16 Apr 2019) Rs 972 Target Price Rs 1,040

ITD Cementation (India) Ltd.

IRB Infrastructure Developers

Outperformance continues

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Residential recovery awaited

Brigade Enterprises BUY RESULTS REVIEW 2QFY16 03 NOV Highlights of the quarter. CMP (as on 03 Nov 2015) Rs 162 Target Price Rs 210

FIRSTSOURCE SOLUTIONS LTD.

V-Guard. On track BUY COMPANY UPDATE 27 SEP 2017

Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal

IRB Infrastructure Developers

Chemicals and Fertilisers

Transcription:

INDUSTRY AUTOS CMP (as on 29 Oct 2018) Rs 268 TP Rs 435 Nifty 10,251 Sensex 34,067 KEY STOCK DATA Bloomberg SUBR IN No. of Shares (mn) 60 MCap (Rsbn) / ($ mn) 16/219 6m avg traded value (Rsmn) 20 STOCK PERFORMANCE (%) 52 Week high / low Rs 444/235 3M 6M 12M Absolute (%) (11.7) (18.3) 1.5 Relative (%) (2.9) (15.7) (1.2) SHAREHOLDING PATTERN (%) Promoters 40.01 FIs & Local MFs 6.71 FPIs 0.55 Public & Others 52.73 Abhishek Jain abhishekkumar.jain@hdfcsec.com +91-22-6171-7314 Good show in tough times Subros delivered strong numbers in 2QFY19 despite several headwinds like slowdown in PVs segment and unfavorable currency movement. Strong growth was attributed to acquiring new business(like compressor for Tata Tiago and Nexon) in core PV AC segment, shift in demand towards petrol variants and strong revenue from other verticals like bus/truck ACs and radiators, Revenue/EBITDA rose 14/9% YoY (beat est). EBITDA margin at 10.5% (-42bps YoY in line expectation), increase in other expenses (led by higher freight and selling & distribution expenses) was offset by oplev. APAT jumped 48% YoY at Rs 238mn supported by lower depreciation (- 13% YoY) and tax. We expect Subros core PV AC business will continue to deliver strong growth (13% CAGR over FY18-21E) led by steady volume growth of MSIL, shift in demand towards petrol variants plus rising wallet share in other key OEMs. More importantly, growth visibility of new businesses like Truck/Bus Aircon, radiators and Condensers is strong (~+20% CAGR over the next 3-5 years) and provides scale and diversification. We expect Subros to generate FCF of Rs ~4bn over FY18-21E (18% of current EV). This will help to deleverage its balance sheet. Expect EPS growth of 32% over FY18-21E. Maintain BUY with TP Rs 435(20xSep-20E EPS) RESULTS REVIEW 2QFY19 30 OCT 2018 Subros BUY Key highlights Gaining market share in PV segment: Subros has gained 300 bps YoY to 42% market share in PV ACS. The company has secured new business from Tata Motors (for Tata Tiago and Nexon) and M&M (for Marrazo). The current capacity utilization has reached 87% and the company is setting up a Greenfield plant in Gujarat to increase capacity from 1.5mn to 2.5mn (1 st phase will be commissioned by Apr-19) by FY20 end. Radiator business: Revenue from radiator business stood at Rs 1.4bn in 1H and the company is targeting revenue of Rs 2.8-2.9bn for FY19. Capex and net debt: The company has guided for capex Rs 1.20bn for FY19 (including Rs 750 mn for Greenfield expansion for Suzuki Motors in Gujarat). Net debt stood at Rs 3.60bn in 1H vs Rs 3.66bn in FY18 end. Raising funds: Subros has raised fund of Rs 2bn through issue of 5.2mn equity shares (~9% equity dilution) on preferential basis to Denso. This money will be used for repayment of Debt and capacity addition. We expect dilution will be EPS accretive and provide strength to balance sheet(effect not incorporated yet) Financial Summary (Rs mn) 2QFY19 2QFY18 YoY (%) 1QFY19 QoQ (%) FY18 FY19E FY20E FY21E Net Sales 5,640 4,972 13 5,317 6 19,129 21,815 25,516 28,588 EBITDA (adj.) 593 544 9 570 4 2,100 2,400 2,883 3,288 APAT 238 160 49 223 7 624 883 1,188 1,423 Diluted EPS (Rs) 4.0 2.7 48.9 3.7 7.0 10.4 14.7 19.8 23.7 P/E (x) 25.7 18.2 13.5 11.3 EV / EBITDA (x) 9.4 8.1 6.5 5.3 RoE (%) 16.6 20.1 22.8 22.8 HDFC securities Institutional Research is also available on Bloomberg HSLB <GO> & Thomson Reuters

Consolidated top-line at Rs 5.6bn (+13.5% YoY) was led by strong growth in PV AC sales (+16% YoY). The company had secured new order for supplying compressor for Baleno, new swift, Tata Tiago and Nexon which boosted overall revenue in H1(20% YoY) EBITDA margin at 10.5% (- 42bps YoY), increase in other expenses (led by higher freight and selling & distribution expenses) was offset by oplev Interest cost increased by 30% YoY (MTM loss of Rs 40.5 mn on foreign currency liabilities), offset by higher other income (due to realized currency gain of Rs 50mn on hedging & MTM on derivative contracts). Quarterly Financials Snapshot: Standalone Particulars (Rs mn) 2QFY19 2QFY18 YoY (%) 1QFY19 QoQ (%) Net sales (incl OOI) 5,640 4,972 13.5 5,317 6.1 Material Expenses 3,962 3,552 11.5 3,736 6.1 Employee Expenses 536 449 19.4 526 1.9 Other Operating Expenses 549 427 28.6 485 13.2 EBITDA 593 544 9.1 570 4.1 Depreciation 199 228 (12.8) 188 6.1 EBIT 394 316 24.9 382 3.1 Other Income 58 29 97.3 41 NA Interest Cost 133 102 30.8 140 (4.9) PBT 318 243 31.1 283 12.4 Tax 80 83 (3.3) 61 32.4 PAT Before EO items 238 160 48.9 223 7.0 EO Items 238 160 48.9 223 7.0 RPAT Post EO items - (9) NA (33) (100.0) APAT 238 151 58.0 189 25.8 Adj EPS 238 160 48.9 223 7.0 Margin Analysis: Standalone 2QFY19 2QFY18 YoY (%) 1QFY19 QoQ (%) Material Expenses % Net Sales 70.2 71.5 (120) 70.3 (2) Employee Expenses % Net Sales 9.5 9.0 47 9.9 (39) Other Expenses % Net Sales 9.7 8.6 115 9.1 61 EBITDA Margin (%) 10.5 10.9 (42) 10.7 (20) Tax Rate (%) 25.2 34.1 (894) 21.4 380 APAT Margin (%) 4.2 3.0 119 3.6 66 Depreciation was lower owing to change in method from WDV to SLM Page 2

Subros core PV AC business will continue to deliver strong growth (13% CAGR over FY18-21E) helped by faster growth in Maruti, Tata Motors and M&M PV sales and market share gain Subros is supplying close to 65/35/27% of the total AC requirement of MSIL/Tata Motors/M&M in PV segment. The demand for truck/buses AC is at a nascent stage today, we expect it to rise significantly. Key Assumptions Segment Rs mn FY17 FY18 FY19E FY20E FY21E Revenue from AC Supply in PV* 14,465 15,949 17,610 20,452 22,941 Revenue from Other business 985 3,130 4,153 5,012 5,595 CV & buses 480 680 1,131 1,735 1,947 Radiator 370 2,200 2,600 2,720 3,000 Home AC 25 50 102 157 198 Transportation refrigeration 10 50 70 100 130 Railways 100 150 250 300 320 Other Operating income 45 50 52 52 53 Total 15,495 19,129 21,815 25,516 28,588, * including aftermarket revenue Change in Estimates In Rs mn New OLD % Change FY19E FY20E FY21E FY19E FY20E FY21E FY19E FY20E FY21E Net Sales 21,815 25,516 28,588 21,815 25,516 28,588 - - - EBITDA 2,400 2,883 3,288 2,400 2,883 3,288 - - - Adj PAT 883 1,188 1,423 883 1,188 1,423 - - - Adj EPS (in Rs) 14.7 19.8 23.7 14.7 19.8 23.7 - - - Source: HDFC sec Inst Research Peer Set Comparison MCap (Rs bn) CMP (Rs/sh) Rating TP Adj EPS (Rs/sh) P/E (x) EV/EBITDA (x) RoE (%) FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E Exide Industries 216 254 BUY 304 8.4 11.3 13.3 30.4 22.5 19.1 18.4 17.0 12.7 14.9 13.9 17.1 Jamna Auto 28 70 BUY 100 3.1 4.0 5.0 22.2 17.3 14.0 11.9 9.6 7.7 33.1 33.9 33.9 Suprajit Engineering 30 228 BUY 289 9.9 12.1 14.5 23.0 18.8 15.7 13.7 11.3 9.5 23.5 23.3 22.8 SwaraJ engines 17 1,402 BUY 2,027 66.1 76.8 89.5 21.2 18.2 15.7 13.0 10.7 8.9 31.3 37.9 37.6 Subros 16 268 BUY 435 10.4 14.7 19.8 25.7 18.2 13.5 17.4 15.2 12.7 16.6 20.1 22.8 Ramkrishna Forging 16 550 BUY 908 29.1 36.8 45.2 18.9 14.9 12.2 8.4 7.0 6.1 15.4 14.8 15.7 NRB Bearings 15 152 BUY 217 9.4 10.5 12.1 16.2 14.4 12.6 9.8 8.4 7.3 26.6 24.7 23.9 JBM Auto 11 268 BUY 560 17.0 24.6 31.1 15.7 10.9 8.6 7.7 5.8 4.8 18.0 22.7 21.7 Lumax Autotech 11 158 BUY 216 6.9 9.7 12.0 23.1 16.3 13.1 10.7 8.3 6.7 11.4 14.0 15.6, *FV (fair Value) Page 3

Net Revenue On The Rise Gross Margin Improved YoY/QoQ.The Company is aiming for Greenfield expansion for Suzuki Motors in Gujarat. Subros to increase capacity from 1.5mn to 2.5mn- with capex Rs 1.30bn that will be spread into 2 years. Maruti Suzuki s total contribution remains strong; above 70% in 1H. 6,000 5,000 4,000 3,000 2,000 1,000-1QFY17 Net Revenue (Rs mn) 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 % YoY (RHS) 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 4QFY18 1QFY19 2QFY19 1,800 1,600 1,400 1,200 1,000 800 600 400 200 - Gross profit(rs. Mn) 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 Gross margin (RHS) 31.50 31.00 30.50 30.00 29.50 29.00 28.50 28.00 27.50 27.00 4QFY18 1QFY19 2QFY19 Subros is targeting to reduce the import of components from 35% to 25% and improve the EBITDA margin by 100-150bps over the next two years. In 1HFY19 import content was 32% The company has guided for capex (incl. new product development and capacity expansion) of Rs 1,200/600mn for FY19/20 respectively. EBITDA Margin Contracted YoY/QoQ EBITDA (Rs mn) EBITDA margin (RHS) 700 14.0 600 12.0 500 10.0 400 8.0 300 6.0 200 4.0 100 2.0 - - 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18 1QFY19 2QFY19 One-year Forward P/E Chart 37.0 34.0 31.0 28.0 25.0 22.0 19.0 16.0 13.0 10.0 P/E (x) Mean +1 SD -1 SD Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Oct-17 Dec-17 Feb-18 Apr-18 Jun-18 Aug-18 Oct-18 Page 4

Income Statement (Standalone) (Rs mn) FY17 FY18 FY19E FY20E FY21E Net Revenues 15,349 19,129 21,815 25,516 28,588 Growth (%) 17.4 24.6 14.0 17.0 12.0 Material Expenses 10,709 13,345 15,249 17,810 19,955 Employee Expenses 1,537 1,881 2,116 2,450 2,716 Other Operating Expenses 1,425 1,803 2,051 2,373 2,630 EBITDA 1,678 2,100 2,400 2,883 3,288 EBITDA Margin (%) 10.9 11.0 11.0 11.3 11.5 EBITDA Growth (%) 10.3 25.2 14.3 20.2 14.0 Depreciation 879 920 825 915 1,005 EBIT 799 1,180 1,574 1,968 2,282 Other Income (Incl. EO Items) (237) 74 78 82 85 Interest 479 412 425 352 275 PBT 82 842 1,227 1,697 2,092 Tax (Incl Deferred) (52) 218 344 509 670 RPAT 134 624 883 1,188 1,423 EO (Loss)/Profit (Net of Tax) (200) - - APAT 341 624 883 1,188 1,423 APAT Growth (%) 42.1 83.1 45.7 34.5 19.7 Adjusted EPS (Rs) 5.7 10.4 14.7 19.8 23.7 EPS Growth (%) 42.1 83.1 41.5 34.5 19.7 Balance Sheet (Standalone) (Rs mn) FY17 FY18 FY19E FY20E FY21E SOURCES OF FUNDS Share Capital - Equity 120 120 120 120 120 Reserves 3,358 3,928 4,631 5,549 6,672 Total Shareholders Funds 3,478 4,048 4,751 5,669 6,792 Minority Interest Long Term Debt 2,359 2,235 1,935 1,635 1,135 Short Term Debt 1,701 1,629 1,609 1,569 1,509 Total Debt 4,060 3,864 3,544 3,204 2,644 Net Deferred Taxes - - - - - Long Term Provisions & Others 63 102 102 102 102 TOTAL SOURCES OF FUNDS 7,601 8,013 8,397 8,975 9,538 APPLICATION OF FUNDS Net Block 5,222 7,126 6,680 6,765 6,759 CWIP 1,241 469 1,269 1,069 800 Investments 25 25 25 25 25 LT Loans & Advances 230 283 504 504 504 Total Non-current Assets 6,718 7,903 8,478 8,362 8,088 Inventories 2,052 2,396 2,510 3,076 3,446 Debtors 1,302 1,614 1,673 1,957 2,115 Other Current Assets 1,108 876 640 796 794 Cash & Equivalents 83 198 80 600 1,315 Total Current Assets 4,545 5,084 4,903 6,429 7,670 Creditors 2,399 4,099 3,458 4,030 4,506 Other Current Liabilities & Provns 1,264 875 1,527 1,786 1,715 Total Current Liabilities 3,663 4,974 4,985 5,817 6,221 Net Current Assets 883 110 (81) 612 1,449 TOTAL APPLICATION OF FUNDS 7,601 8,013 8,397 8,975 9,538 Page 5

Cash Flow Statement(Standalone) (Rsmn) FY17 FY18 FY19E FY20E FY21E Reported PBT 82 842 1,227 1,697 2,092 Non-operating & EO items - - - - Interest expenses 479 412 425 352 275 Depreciation 879 920 825 915 1,005 Working Capital Change 348 975 (76) (174) (122) Tax Paid (243) (218) (344) (509) (670) Other operating Items 22 OPERATING CASH FLOW ( a ) 1,567 2,931 2,058 2,282 2,581 Capex (1,170) (2,052) (1,179) (800) (732) Free cash flow (FCF) 397 880 879 1,482 1,850 Investments - - - - Non-operating Income - - - - INVESTING CASH FLOW ( b ) (1,170) (2,052) (1,179) (800) (732) Debt Issuance/(Repaid) 79 (196) (320) (340) (560) Interest Expenses (479) (412) (425) (352) (275) FCFE (2) 271 134 790 1,015 Share Capital Issuance (94) (79) (216) (324) (360) Dividend FINANCING CASH FLOW ( c ) (384) (765) (997) (962) (1,135) NET CASH FLOW (a+b+c) 13 115 (118) 520 715 Opening bal of Cash & Cash Equa 70 83 198 80 600 Closing Cash & Equivalents 83 198 80 600 1,315 Key Ratios (Standalone) FY17 FY18 FY19E FY20E FY21E PROFITABILITY (%) GPM 30.2 30.2 30.1 30.2 30.2 EBITDA Margin 10.9 11.0 11.0 11.3 11.5 APAT Margin 2.2 3.3 4.0 4.7 5.0 RoE 10.0 16.6 20.1 22.8 22.8 RoIC (or Core RoCE) 9.0 11.5 14.0 17.0 19.5 RoCE 9.8 11.9 14.5 16.5 17.4 EFFICIENCY Tax Rate (%) (62.7) 25.8 28.0 30.0 32.0 Fixed Asset Turnover (x) 1.40 1.55 1.58 1.90 2.11 Inventory (days) 48.8 45.7 42.0 44.0 44.0 Debtors (days) 31.0 30.8 28.0 28.0 27.0 Other Current Assets (days) 26.3 16.7 10.7 11.4 10.1 Payables (days) 57.0 78.2 57.9 57.7 57.5 Other Current Liab&Provns (days) 30.1 16.7 25.6 25.6 21.9 Cash Conversion Cycle (days) 19.0 (1.7) (2.7) 0.2 1.7 Debt/EBITDA (x) 2.4 1.8 1.5 1.1 0.8 Net D/E (x) 1.1 0.9 0.7 0.5 0.2 Interest Coverage (x) 1.7 2.9 3.7 5.6 8.3 PER SHARE DATA (Rs) EPS 5.7 10.4 14.7 19.8 23.7 CEPS 16.9 25.7 28.5 35.1 40.5 Dividend 1.3 1.1 3.0 4.5 5.0 Book Value 58.0 67.5 79.2 94.5 113.2 VALUATION P/E (x) 47.2 25.7 18.2 13.5 11.3 P/BV (x) 4.6 4.0 3.4 2.8 2.4 EV/EBITDA (x) 12.0 9.4 8.1 6.5 5.3 EV/Revenues (x) 1.3 1.0 0.9 0.7 0.6 OCF/EV (%) 7.8 14.8 10.5 12.2 14.8 FCF/EV (%) 2.0 4.5 4.5 7.9 10.6 FCFE/Mkt Cap (%) (0.0) 1.7 0.8 4.9 6.3 Dividend Yield (%) 0.5 0.4 1.1 1.7 1.9 Page 6

RECOMMENDATION HISTORY Subros TP 450 400 350 300 250 200 150 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Date CMP Reco Target 11-Oct-17 252 BUY 318 2-Nov-17 267 BUY 318 9-Jan-18 377 NEU 375 12-Apr-18 340 NEU 375 23-Apr-18 330 BUY 384 29-May-18 326 BUY 384 9-Jul-18 281 BUY 384 10-Aug-18 335 BUY 435 8-Oct-18 275 BUY 435 30-Oct-18 268 BUY 435 Rating Definitions BUY : Where the stock is expected to deliver more than 10% returns over the next 12 month period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period Page 7

Disclosure: I, Abhishek Jain, MBA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. Page 8

HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013 Board : +91-22-6171 7330 www.hdfcsec.com Page 9